President Biden and former President Trump are both claiming credit for the $35 insulin co-pay cap under Medicare, but the idea actually originated from a pharmaceutical company, Eli Lilly. The company proposed the concept in 2019, allowing Medicare insurance plans to offer $35 monthly insulin. Both politicians are vying for recognition of this initiative, which has been widely publicized.
Biden-Harris Comms Director Michael Tyler: President Biden has a historic record of accomplishment. He has created 15 million jobs, 800,000 being manufacturing jobs. He capped insulin at $35 for seniors and wants to expand that. He's creating a fairer tax code and making sure… https://t.co/e93oazad4H
Eli Lilly first proposed an experiment allowing Medicare insurance plans to offer $35 monthly insulin in 2019. But both Biden and Trump are fighting to claim credit for the idea. https://t.co/XZ6jgHXCDq
Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea https://t.co/gKbH7AFfvv Interesting story via @rachelcohrs @statnews
Both President Biden and former President Trump love to claim credit for getting more Americans $35 insulin. But the credit should actually go to a giant pharmaceutical company. https://t.co/mnPOdTx0wP
EXCLUSIVE: On the trail and in TV ads, Biden and Trump are each claiming credit for $35 insulin. Actually, it was a pharma giant’s idea https://t.co/XuFmqLPndV via @statnews @rachelcohrs
There’s that widely publicized $35 cap on insulin prices — but who came up with that magic number? Both Presidents Trump and Biden have claimed it was their doing, but… https://t.co/7cjZKR49ey
Biden and Trump are fighting to claim credit for $35 insulin under Medicare. It was actually a pharma giant’s idea @RachelCohrs Zhang reports for @STATNews https://t.co/vB18lTG4qr
$35 insuline co-pay cap, brought to you by Biden, I mean Trump, I mean: big pharma: https://t.co/BJ3Q7baKfR